NKF KDOQI GUIDELINES
K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease
Tables
Figures
Acronyms and Abbreviations
Work Group Membership and Evidence Review Team
KDOQI Advisory Board Members
Foreword
Executive Summary
Background
Clinical Practice Guidelines
- Guideline 1. Goals of Antihypertensive Therapy in CKD
- Guideline 2. Evaluation of Patients With CKD or Hypertension
- Guideline 3. Measurement of Blood Pressure in Adults
- Guideline 4. Evaluation for Renal Artery Disease
- Guideline 5. Education on Self-Management Behavior
- Guideline 6. Dietary and Other Therapeutic Lifestyle Changes in Adults
- Guideline 7. Pharmacological Therapy: Use of Antihypertensive Agents in CKD
- Guideline 8. Pharmacological Therapy: Diabetic Kidney Disease
- Guideline 9. Pharmacological Therapy: Nondiabetic Kidney Disease
- Guideline 10. Pharmacological Therapy: Kidney Disease in the Kidney Transplant Recipient
- Guideline 11. Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in CKD
- Guideline 12. Use of Diuretics in CKD
- Guideline 13. Special Considerations in Children
Appendices